Pre-Diagnostic Changes in the Metabolome of Inflammatory Bowel Disease
Clinical Gastroenterology and Hepatology · 2026-09 · 24 (9) · 2560-2570
DOI: 10.1016/j.cgh.2026.02.011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-09. Verfasst von Camilla Engel Lemser und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine, PREDICT Center for Molecular Prediction of Inflammatory Bowel Disease, Aalborg University, Copenhagen, Denmark. Elec…. Hauptthemen laut MEDLINE: Metabolome, Inflammatory Bowel Diseases, Biomarkers, Serum. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Novo Nordisk Fonden, Danish National Research Foundation.
Abstract (Originalsprache)
BACKGROUND & AIMS: Serum metabolites reflect genetics, environmental exposures, and the gut microbiome. We analyzed changes in the serum metabolome up to 14 years before the diagnosis of inflammatory bowel disease (IBD) to identify early biomarkers and uncover pathophysiological changes during the pre-diagnostic phase. METHODS: The Danish PREDICT cohort was established by cross-linking nationwide health registries with the Danish National Biobank to identify patients with pre-diagnostic serum samples. A total of 169 individuals with IBD (72 Crohn's disease [CD]; 97 ulcerative colitis [UC]) and 169 matched controls were included for untargeted profiling to investigate pre-diagnostic alterations in the serum metabolome, timing of metabolomic changes, and their ability to predict IBD. RESULTS: A total of 1206 metabolites were significantly altered prior to IBD diagnosis (Padj 1000 metabolites up to 14 years prior to diagnosis of IBD, most pronounced in individuals with later CD. Our findings suggest a long pre-clinical phase of IBD, where mucosal breakdown contributes to production of inflammation-modulating lipids.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Medicine, PREDICT Center for Molecular Prediction of Inflammatory Bowel Disease, Aalborg University, Copenhagen, Denmark. Electronic address: celem@dcm.aau.dk.
- Department of Clinical Medicine, PREDICT Center for Molecular Prediction of Inflammatory Bowel Disease, Aalborg University, Copenhagen, Denmark.
- Department of Congenital Disorders, Danish Center for Neonatal Screening, Statens Serum Institut, Copenhagen, Denmark.
- Department of Clinical Medicine, PREDICT Center for Molecular Prediction of Inflammatory Bowel Disease, Aalborg University, Copenhagen, Denmark; Department of Gastroenterology and Hepatology, Aalborg University Hospital…
- Department of Clinical Medicine, PREDICT Center for Molecular Prediction of Inflammatory Bowel Disease, Aalborg University, Copenhagen, Denmark; Department of Congenital Disorders, Danish Center for Neonatal Screening,…
Förderung
- Novo Nordisk Fonden
- Danish National Research Foundation
Zitieren
APA
Lemser, C. E., Koziol, A., Boelt, S. G., MacSween, N., Ernst, M., Jess, T., & Ottosson, F. (2026). Pre-Diagnostic Changes in the Metabolome of Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology, 24(9), 2560-2570. https://doi.org/10.1016/j.cgh.2026.02.011
Vancouver
Lemser CE, Koziol A, Boelt SG, MacSween N, Ernst M, Jess T, et al. Pre-Diagnostic Changes in the Metabolome of Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology. 2026;24(9):2560-2570. doi:10.1016/j.cgh.2026.02.011
BibTeX
@article{Lemser2026,
author = {Lemser, Camilla Engel and Koziol, Adam and Boelt, Sanne Grundvad and MacSween, Nadia and Ernst, Madeleine and Jess, Tine and Ottosson, Filip},
title = {Pre-Diagnostic Changes in the Metabolome of Inflammatory Bowel Disease},
journal = {Clinical Gastroenterology and Hepatology},
year = {2026},
volume = {24},
number = {9},
pages = {2560--2570},
doi = {10.1016/j.cgh.2026.02.011}
}
EUVIMED